#IGMS

@newsen.bsky.social

4 months ago

Birdseye Revolutionizes Logistics with New Facility Supervisor Portal for Enhanced Security Birdseye Security Solutions has launched the Facility Supervisor Portal, offering logistics teams better visibility while streamlining operations and cutting costs.

Birdseye Revolutionizes Logistics with New Facility Supervisor Portal for Enhanced Security #USA #Dallas #IGMS #Birdseye_Security #Facility_Supervisor

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

5 months ago

Birdseye Launches iGMS: Transforming Gate Operations with AI Technology Birdseye Security Solutions introduces iGMS, a groundbreaking Intelligent Gate Management System, enhancing security and efficiency in logistics.

Birdseye Launches iGMS: Transforming Gate Operations with AI Technology #USA #Dallas #AI_Technology #IGMS #Birdseye_Security

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

8 months ago

Investigation into GMS, IGMS, MRC and GRYP Mergers: What Shareholders Should Know Class Action Attorney Juan Monteverde investigates multiple mergers, emphasizing their implications for shareholders of GMS, IGMS, MRC, and GRYP.

Investigation into GMS, IGMS, MRC and GRYP Mergers: What Shareholders Should Know #USA #New_York #GMS #MRC #IGMS #GRYP

0 0 0 0

Small Cap Strategist

@smcapstrategist.bsky.social

8 months ago

SmCpStr Technicals – Technical Indicators for Small-cap Stocks

Small-cap stocks gapping up in trading Tue Jul 1st - #BGLC #VVOS #MESO #IGMS #CLRO #ATAI #WOLF #HUYA - More: crystalequityresearch.com/SmCpStr/ - #smallcap

0 0 0 0

PRISM MarketView

@prismmarketview.bsky.social

8 months ago

Microscopic 3D rendering of antibodies interacting in a biological environment, representing innovative immunotherapy research by IGM Biosciences.

Biotech M&A Alert:
IGM Biosciences (NASDAQ: #IGMS) is being acquired by Concentra Biosciences in a cash + CVR deal that could unlock even more value for shareholders. Stock is up 18% as the market reacts. Deal expected to close by August!
prismmarketview.com/igm-bioscien...

0 0 0 0

StockTitan

@stocktitan.net

8 months ago

IGM Biosciences Enters into Agreement to Be Acquired by Concentra Biosciences for $1.247 in Cash per Share Plus a Contingent Value Right IGM Biosciences (NASDAQ: IGMS), a biotechnology company focused on engineered IgM-based therapeutic antibodies, has announced a definitive merger agreement to be acquired by Concentra Biosciences in a structured deal.The transaction includes $1.247 in cash per share plus a non-tradeable contingent value right (CVR). The CVR entitles shareholders to receive 100% of IGM's closing net cash exceeding $82.0 million and 80% of net proceeds from any disposition of certain product candidates and intellectual property within one year post-closing.Concentra will commence a tender offer by July 16, 2025, with the merger expected to close in August 2025. The deal requires majority shareholder approval and minimum cash conditions of $82.0 million at closing.

#IGMS IGM Biosciences Enters into Agreement to Be Acquired by Concentra Biosciences for $1.247 in Cash per Share Plus a Contingent Value Right

www.stocktitan.net/news/IGMS/igm-bioscience...

0 0 0 0

StockTitan

@stocktitan.net

1 year ago

IGM Biosciences Halts Key Drug Programs, Cuts 73% of Workforce Amid Clinical Setbacks IGM Biosciences discontinues imvotamab and IGM-2644 programs after disappointing Phase 1b results in autoimmune diseases, implements major restructuring with $183.8M cash reserve.

#IGMS IGM Biosciences Provides Strategic Update on Autoimmunity Pipeline Programs

www.stocktitan.net/news/IGMS/igm-bioscience...

0 0 0 0